This is a randomized, double-blind (dose-masked), single-dose crossover study to investigate the pharmacokinetics of a novel delivery method and formulation of different doses of CD/LD in normal volunteers.
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Adult healthy male or female
Age 18 to 65 years
Willingness and ability to complete study procedures
You may not be if
medical conditions that require taking medications regularly.
